The final window for shareholders to exercise subscription rights in Mutares SE & Co. KGaA’s capital increase closed today. Rights not utilized expire worthless. The offering allows shareholders to subscribe to one new share for every five held at a price of EUR 24.50, aligning closely with the stock’s recent trading level.
This capital action triggers a significant, permanent shift in the investment company’s ownership structure. The family pool surrounding founder Robin Laik will see its voting rights diluted to just under 24%, falling below the critical 25% threshold. Without selling a single share, the family formally loses its blocking minority, stripping its veto power over certain shareholder resolutions.
Proceeds from the offering are earmarked for a dual strategic push. Approximately 80% will fund portfolio expansion, with a sharp focus on the United States. The company, which already has an office in Chicago, plans a second US location to capitalize on a pipeline of potential deals representing nearly five billion euros in revenue. The remaining 20% will bolster the balance sheet to address a specific covenant issue.
At the end of 2025, Mutares missed an agreed-upon target for its net debt-to-equity ratio. Management has requested a waiver from bondholders until the end of June. Concurrently, a detailed repayment plan is in motion, with the company committed to buying back at least EUR 25 million of its 2023/2027 bond per quarter starting in Q2 2026.
Should investors sell immediately? Or is it worth buying Mutares?
The institutional placement preceding the rights offering saw strong demand. Roughly 1.08 million shares were placed with over 30 long-term investors at the EUR 24.50 issue price, with the order book nearly three times oversubscribed. More than 60% of this demand originated from international investors, primarily in the US and UK.
In a parallel portfolio move, Mutares recently completed the sale of logistics provider inTime Group to the UK’s Tawin Holdings Group. This exit exemplifies the firm’s classic investment model, having acquired, restructured, and sold the company in less than a year.
Financially, Mutares reported 2025 group revenue of EUR 6.5 billion and a holding company net income of EUR 130.4 million. Guidance for 2026 targets revenue between EUR 7.9 billion and EUR 9.1 billion, with holding net income projected in a range of EUR 165 million to EUR 200 million.
The stock recently touched a 52-week low of EUR 24.90, bringing its year-to-date decline to over 16%. It currently trades around EUR 25.05. The next key date is April 28, when the new shares from the rights issue will be delivered and admitted to trading. The company will also publish its full, audited annual report for 2025 on that day.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from April 21 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 21.
Mutares: Buy or sell? Read more here...









